Gillette India (507815) Q4 00/01 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 00/01 earnings summary
2 Nov, 2026Executive summary
FY2001 focused on restructuring, productivity and freeing working capital amid an economic slowdown; grooming brands strengthened market share.
Reported net loss of Rs. 27.79 crore reflected a one-time Rs. 60.64 crore charge related to closing the Duracell plant at Manesar.
Management expected a return to profitability in 2002, supported by corrective actions, marketing investment, cost reduction and improved asset use.
Financial highlights
Sales revenue fell 4% to Rs. 495 crore from Rs. 517 crore, primarily due to trade destocking and lower traded Braun and Oral Care sales.
Profit before extraordinary items and tax was Rs. 18.70 crore, versus Rs. 22.62 crore in FY2000; reported loss before tax was Rs. 41.94 crore.
Net loss after tax was Rs. 27.79 crore, compared with net profit of Rs. 26.42 crore in FY2000.
Recommended dividend increased to Rs. 2.25 per share, despite the reported loss, based on underlying business fundamentals.
Outlook and guidance
Management expected to be virtually debt-free by the end of FY2002, following debt repayment using the capital grant.
Directors expected a return to profitability and strong profit gains in 2002, citing FY2001 corrective measures and focus on marketing, costs, productivity and asset management.
Q1 2002 showed a positive trend in grooming; the Rs. 5 crore consumer promotion and FIFA World Cup sponsorship were expected to support upcoming sales.
Successful trade destocking was expected to support stronger demand-pull sales in the coming year.
Latest events from Gillette India
- Q2 and H1 profit advanced, led by stronger Grooming performance.507815
Q2 26/27 - 9M growth and grooming expansion offset slow shaving demand and a difficult market outlook.507815
Q4 97/98 - Sales rose 4%, PAT grew 35%, and Duracell exited the portfolio.507815
Q4 15/16 - Sales climbed 48%, powered by shaving-system launches and expanding Oral-B distribution.507815
Q4 96/97 - Sales topped Rs.250 crore as shaving products drove growth and expansion plans advanced.507815
Q4 98/99 - A transformative merger expanded the portfolio as tax write-backs lifted reported PAT.507815
Q4 99/00 - Net profit surged 594% as restructuring and continuing-business sales growth drove a turnaround.507815
Q4 02/03 - Restructuring restored profitability and refocused growth on core grooming and alkaline products.507815
Q4 01/02 - Record FY2004 profit and broad-based category growth supported an 85% dividend.507815
Q4 03/04